172 related articles for article (PubMed ID: 28629988)
1. 4'-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency.
Hotard AL; He B; Nichol ST; Spiropoulou CF; Lo MK
Antiviral Res; 2017 Aug; 144():147-152. PubMed ID: 28629988
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of paramyxoviruses and filoviruses to inhibition by 2'-monofluoro- and 2'-difluoro-4'-azidocytidine analogs.
Lo MK; Jordan PC; Stevens S; Tam Y; Deval J; Nichol ST; Spiropoulou CF
Antiviral Res; 2018 May; 153():101-113. PubMed ID: 29601894
[TBL] [Abstract][Full Text] [Related]
3. Nipah and Hendra Viruses: Deadly Zoonotic Paramyxoviruses with the Potential to Cause the Next Pandemic.
Gazal S; Sharma N; Gazal S; Tikoo M; Shikha D; Badroo GA; Rashid M; Lee SJ
Pathogens; 2022 Nov; 11(12):. PubMed ID: 36558753
[TBL] [Abstract][Full Text] [Related]
4. Hendra and nipah infection: pathology, models and potential therapies.
Vigant F; Lee B
Infect Disord Drug Targets; 2011 Jun; 11(3):315-36. PubMed ID: 21488828
[TBL] [Abstract][Full Text] [Related]
5. Hendra and Nipah viruses: pathogenesis and therapeutics.
Eaton BT; Broder CC; Wang LF
Curr Mol Med; 2005 Dec; 5(8):805-16. PubMed ID: 16375714
[TBL] [Abstract][Full Text] [Related]
6. [Nipah and Hendra virus infectious diseases].
Yoneda M
Nihon Rinsho; 2016 Dec; 74(12):1973-1978. PubMed ID: 30550652
[TBL] [Abstract][Full Text] [Related]
7. Favipiravir (T-705) protects against Nipah virus infection in the hamster model.
Dawes BE; Kalveram B; Ikegami T; Juelich T; Smith JK; Zhang L; Park A; Lee B; Komeno T; Furuta Y; Freiberg AN
Sci Rep; 2018 May; 8(1):7604. PubMed ID: 29765101
[TBL] [Abstract][Full Text] [Related]
8. Nipah and Hendra Virus Nucleoproteins Inhibit Nuclear Accumulation of Signal Transducer and Activator of Transcription 1 (STAT1) and STAT2 by Interfering with Their Complex Formation.
Sugai A; Sato H; Takayama I; Yoneda M; Kai C
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835499
[TBL] [Abstract][Full Text] [Related]
9. Potent in vitro activity of β-D-4'-chloromethyl-2'-deoxy-2'-fluorocytidine against Nipah virus.
Lo MK; Amblard F; Flint M; Chatterjee P; Kasthuri M; Li C; Russell O; Verma K; Bassit L; Schinazi RF; Nichol ST; Spiropoulou CF
Antiviral Res; 2020 Mar; 175():104712. PubMed ID: 31935422
[TBL] [Abstract][Full Text] [Related]
10. Nonhuman Primate Models for Nipah and Hendra Virus Countermeasure Evaluation.
Mire CE; Satterfield BA; Geisbert TW
Methods Mol Biol; 2023; 2682():159-173. PubMed ID: 37610581
[TBL] [Abstract][Full Text] [Related]
11. The application of phosphoramidate ProTide technology to the potent anti-HCV compound 4'-azidocytidine (R1479).
McGuigan C; Kelleher MR; Perrone P; Mulready S; Luoni G; Daverio F; Rajyaguru S; Le Pogam S; Najera I; Martin JA; Klumpp K; Smith DB
Bioorg Med Chem Lett; 2009 Aug; 19(15):4250-4. PubMed ID: 19505826
[TBL] [Abstract][Full Text] [Related]
12. Chemical stability of 4'-azidocytidine and its prodrug balapiravir.
Li F; Wu X; Hadig X; Huang S; Hong L; Tran T; Brandl M; Alfredson T
Drug Dev Ind Pharm; 2010 Apr; 36(4):413-20. PubMed ID: 19778160
[TBL] [Abstract][Full Text] [Related]
13. Novel indole-2-carboxamide compounds are potent broad-spectrum antivirals active against western equine encephalitis virus in vivo.
Delekta PC; Dobry CJ; Sindac JA; Barraza SJ; Blakely PK; Xiang J; Kirchhoff PD; Keep RF; Irani DN; Larsen SD; Miller DJ
J Virol; 2014 Oct; 88(19):11199-214. PubMed ID: 25031353
[TBL] [Abstract][Full Text] [Related]
14. Host evasion by emerging paramyxoviruses: Hendra virus and Nipah virus v proteins inhibit interferon signaling.
Rodriguez JJ; Horvath CM
Viral Immunol; 2004; 17(2):210-9. PubMed ID: 15279700
[TBL] [Abstract][Full Text] [Related]
15. Emerging paramyxoviruses: molecular mechanisms and antiviral strategies.
Aguilar HC; Lee B
Expert Rev Mol Med; 2011 Feb; 13():e6. PubMed ID: 21345285
[TBL] [Abstract][Full Text] [Related]
16. Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters.
Jochmans D; van Nieuwkoop S; Smits SL; Neyts J; Fouchier RA; van den Hoogen BG
Antimicrob Agents Chemother; 2016 Aug; 60(8):4620-9. PubMed ID: 27185803
[TBL] [Abstract][Full Text] [Related]
17. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
[TBL] [Abstract][Full Text] [Related]
18. Developments towards effective treatments for Nipah and Hendra virus infection.
Bossart KN; Broder CC
Expert Rev Anti Infect Ther; 2006 Feb; 4(1):43-55. PubMed ID: 16441208
[TBL] [Abstract][Full Text] [Related]
19. Henipavirus pathogenesis and antiviral approaches.
Mathieu C; Horvat B
Expert Rev Anti Infect Ther; 2015 Mar; 13(3):343-54. PubMed ID: 25634624
[TBL] [Abstract][Full Text] [Related]
20. Hendra and Nipah infection: emerging paramyxoviruses.
Aljofan M
Virus Res; 2013 Nov; 177(2):119-26. PubMed ID: 23954578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
